High prevalence of abnormal glucose metabolism in young adult patients with complex congenital heart disease

American Heart Journal

Volumn 158, Issue 1, 2009, Pages 30-39

  Ohuchi, Hideo ^a   Miyamoto, Yoshihiro ^a   Yamamoto, Masaki ^a   Ishihara, Haruko ^a   Takata, Hidemi ^a   Miyazaki, Aya ^a   Yamada, Osamu ^a   Yagihara, Toshikatsu ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RENIN;

ADULT; ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; EXERCISE; FEMALE; FONTAN PROCEDURE; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PLASMA RENIN ACTIVITY; PREVALENCE; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; ANTHROPOMETRY; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; EXERCISE TEST; FEMALE; GLUCOSE TOLERANCE TEST; HEART DEFECTS, CONGENITAL; HEMODYNAMICS; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; JAPAN; LIPIDS; MALE; MASS SCREENING; MIDDLE AGED; PROSPECTIVE STUDIES; REFERENCE VALUES; YOUNG ADULT;

EID: 67049167013     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.04.021     Document Type: Article

References (44)

1. Dearani J.A., Connolly H.M., Martinez R., et al. Caring for adults with congenital cardiac disease: successes and challenges for 2007 and beyond. Cardiol Young 17 Suppl 2 (2007) 87-96
2. Sharma R., Bolger A.P., Li W., et al. Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease. Am J Cardiol 92 (2003) 188-193
3. McMurray J.J., Pfeffer M.A., Swedberg K., et al. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?. Circulation 110 (2004) 3281-3288
4. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161 (2001)
5. Chiasson J.L., Josse R.G., Gomis R., et al. STOP-NIDDM Trial Research Group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 290 (2003) 486-494
6. Bartnik M., Malmberg K., Norhammar A., et al. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J 25 (2004) 1990-1997
7. Witteles R.M., Tang W.H., Jamali A.H., et al. Insulin resistance in idiopathic dilated cardiomyopathy: a possible etiologic link. J Am Coll Cardiol 44 (2004) 78-81
8. Ohuchi H., Hasegawa S., Yasuda K., et al. Severely impaired cardiac autonomic nervous activity after the Fontan operation. Circulation 104 (2001) 1513-
9. Ohuchi H., Takasugi H., Ohashi H., et al. Abnormalities of neurohormonal and cardiac autonomic nervous activities relate poorly to functional status in Fontan patients. Circulation 110 (2004) 2601-2608
10. Mori K. Automated measurement of catecholamines in urine, plasma and hemogenates by high-performance liquid chromatography with fluorometric detection. J Chromatography 218 (1981) 631-637
11. Kono M., Yamaguchi A., Tsuji T., et al. An immunoradiometric assay for brain natriuretic peptide in human plasma. Kaku Igaku 13 (1993) 2-7
12. Ikeda I., Iinuma K., Takai M., et al. Measurement of plasma renin activity by a simple solid phase radioimmunoassay. J Clin Endocrinol Metab 54 (1982) 423-428
13. Puavilai G., Chanprasertyotin S., and Sriphrapradaeng A. Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria. World Health Organization. Diabetes Res Clin Pract 44 (1999) 21-26
14. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
15. Matsuda M., and DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing. Comparison with the euglycemic insulin clamp. Diabetes Care 22 (1999) 1462-1470
16. Ohuchi H., Nakajima T., Kawade M., et al. Measurement and validity of the ventilatory threshold in patients with congenital heart disease. Pediatr Cardiol 17 (1996) 7-14
17. Solomon S.D., Wang D., Finn P., et al. Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 110 (2004) 2180-2183
18. Grandinetti A., Kaholokula J.K., Theriault A.G., et al. Prevalence of diabetes and glucose intolerance in an ethnically diverse rural community of Hawaii. Ethn Dis 17 (2007) 250-255
19. Swan J.W., Anker S.D., Walton C., et al. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol 30 (1997) 527-532
20. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet 354 (1999) 617-621
21. Hashimoto K., Ikewaki K., Yagi H., et al. Glucose intolerance is common in Japanese patients with acute coronary syndrome who were not previously diagnosed with diabetes. Diabetes Care 28 (2005) 1182-1186
22. Wei M., Gibbons L.W., Mitchell T.L., et al. Low fasting plasma glucose level as a predictor of cardiovascular disease and all-cause mortality. Circulation 101 (2000) 2047-2052
23. Dandona P., Aljada A., Chaudhuri A., et al. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111 (2005) 1448-1454
24. Greenberg A.S., and Obin M.S. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 83 (2006) 461S-465S
25. Marangou A.G., Alford F.P., Ward G., et al. Hormonal effects of norepinephrine on acute glucose disposal in humans: a minimal model analysis. Metabolism 37 (1988) 885-891
26. Desideri G., Ferri C., Bellini C., et al. Effects of ACE inhibition on spontaneous and insulin-stimulated endothelin-1 secretion: in vitro and in vivo studies. Diabetes 46 (1997) 81-86
27. Baron A.D. The coupling of glucose metabolism and perfusion in human skeletal muscle: the potential role of endothelium-derived nitric oxide. Diabetes 45 Suppl (1996) S105-S109
28. Ran J., Hirano T., Fukui T., et al. Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance. Metabolism 55 (2006) 478-488
29. Kumashiro N., Tamura Y., Uchida T., et al, Impact of oxidative stress and peroxisome proliferator-activated receptor gamma coactivator-1alpha in hepatic insulin resistance. Diabetes;57:2083-2091.
30. Zillich A.J., Garg J., Basu S., et al. Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension 48 (2006) 219-224
31. Marchesini G., Brizi M., Morselli-Labate A.M., et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 107 (1999) 450-455
32. Meyer C., Woerle H.J., Dostou J.M., et al. Abnormal renal, hepatic, and muscle glucose metabolism following glucose ingestion in type 2 diabetes. Am J Physiol Endocrinol Metab 287 (2004) E1049-E1056
33. Dimopoulos K., Diller G.P., Koltsida E., et al. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation 117 (2008) 2320-2328
34. DeFronzo R.A., Jacot E., Jequier E., et al. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30 (1981) 1000-1007
35. Lyssenko V., Jonsson A., Almgrem P., et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. New Engl J Med 359 (2008) 2220-2232
36. Vermes E., Tardif J.C., Bourassa M.G., et al. Enalapril reduces the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD). Circulation 107 (2003) 2926-2931
37. Inoguchi T., Li P., Umeda F., et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49 (2000) 1939-1945
38. Yusuf S., Ostergren J.B., Gerstein H.C., et al. Candesartan in Heart Failure-Assessment of Reduction in Mortality and Morbidity Program Investigators. Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure. Circulation 112 (2005) 48-53
39. Rosenthal D.N., Friedman A.H., Kleinman C.S., et al. Thromboembolic complications after Fontan operations. Circulation 92 Suppl (1995) II287-II293
40. Nordt T.K., Sawa H., Fujii S., et al. Induction of plasminogen activator inhibitor type-1 (PAI-1) by proinsulin and insulin in vivo. Circulation 91 (1995) 764-770
41. Torp-Pedersen C., Metra M., Charlesworth A., et al. COMET investigators. Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET). Heart 93 (2007) 968-977
42. Ahmed A., Husain A., Love T.E., et al. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J 27 (2006) 1431-1439
43. HAPO Study Cooperative Research Group, Metzger B.E., Lowe L.P., Dyer A.R., et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358 (2008) 1991-2002
44. Ashrafian H., Frenneaux M.P., and Opie L.H. Metabolic mechanisms in heart failure. Circulation 116 (2007) 434-448